SCHEMBL12447346

SCHEMBL12447346

CCC(=O)N1CCC(c2ccccc2)C1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.71
▸ POLB P06746 1/20 0.71
▸ RAB9A P51151 9/20 0.62
▸ LMNA P02545 2/20 0.62
▸ MAPK1 P28482 2/20 0.60
▸ SMN1; SMN2 Q16637 7/20 0.59
▸ MAPT P10636 7/20 0.59
▸ NPC1 O15118 6/20 0.59
▸ GAA P10253 2/20 0.59
▸ HTT P42858 2/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ CYP2D6 P10635 1/20 0.59
▸ CYP2C9 P11712 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ STAT1 P42224 1/20 0.59
▸ TP53 P04637 2/20 0.58
▸ KMT2A Q03164 2/20 0.58
▸ HPGD P15428 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12447962 1.00 ALDH1A1 (0.71) ALDH1A1POLBRAB9ALMNAMAPK1
SCHEMBL14035659 0.92 ALDH1A1 (0.61) ALDH1A1POLBRAB9ALMNAMAPK1
SCHEMBL4034093 0.90 ALDH1A1 (0.57) ALDH1A1POLBRAB9ALMNASMN1; SMN2
SCHEMBL2135668 0.88 ALDH1A1 (0.68) ALDH1A1POLBRAB9ALMNAMAPK1
SCHEMBL12282136 0.88 ALDH1A1 (0.68) ALDH1A1POLBRAB9ALMNAMAPK1
SCHEMBL19493589 0.86 ALDH1A1 (0.73) ALDH1A1POLBRAB9ALMNAMAPK1
SCHEMBL2132155 0.85 SMN1; SMN2 (0.66) ALDH1A1POLBRAB9ALMNAMAPK1
SCHEMBL27957974 0.85 MAPT (0.60) ALDH1A1POLBRAB9ALMNAMAPK1
SCHEMBL16785545 0.84 RAB9A (0.62) ALDH1A1POLBRAB9ALMNAMAPK1
SCHEMBL2133360 0.84 MAPT (0.65) ALDH1A1POLBRAB9ALMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230019032-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2023-01-19 — — US disclosed
US-8846684-B2 Arbovirus inhibitors and uses thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-09-30 — — US disclosed
EP-1786815-B1 SPIRO COMPOUNDS AND METHODS FOR THE MODULATION OF CHEMOKINE RECEPTOR ACTIVITY VIROCHEM PHARMA INC (CA) 2011-08-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230019032-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS MAPK1, ALK, MAP3K1 ALDH1A1 1598/4885POLB 2980/4885RAB9A 3664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback